dsm-firmenich launches naturally potent DHA algal oil

dsm-firmenich, innovators in health, nutrition, and beauty, has grown its leading-edge life’s® portfolio with the worldwide launch of life’sDHA® B54-0100 – the company’s most naturally potent algal docosahexaenoic acid (DHA) oil to date. The breakthrough ingredient not only meets rising demand for sustainable, plant-based supplements, but also tackles key challenges such as pill fatigue and convenience, making the benefits of DHA available to more consumers globally.

life’sDHA® B54-0100 delivers 545 mg pure DHA and 80 mg eicosapentaenoic acid (EPA) per gram (equivalent to 620 mg of omega-3 triglycerides), enabling the development of smaller, more cost-effective capsules with higher DHA concentrations. Combined with its superior sensory profile, free from fishy odors and aftertaste, life’sDHA® B54-0100 also opens up new possibilities for more appealing supplement formats, like gummies, chews and candyceuticals – addressing limitations associated with traditional fish-sourced ingredients. Moreover, by sourcing the DHA directly from algae under strictly controlled conditions, dsm-firmenich’s life’sDHA® B54-0100 solution provides a sustainable and contaminant-free alternative.

Addressing global omega-3 deficiency with innovative solutions
“Fish oil supply is not limitless. But algae are. That’s why we introduced life’s® to the market,” comments Brent MacDonald, Business Development Director, Algal Lipids, HNC. “Our mission is to close the omega-3 deficiency gap and ensure that the 80% of the global population currently not meeting daily recommended intake can benefit from these essential nutrients without harming marine life. life’sDHA® B54-0100 can help to achieve exactly that. It brings all the science-based benefits of DHA but at lower inclusion levels, transforms the sensory experience of omega-3 consumption and is good for the planet; making it ideal for applications across the supplement space. Plus, since it's derived from algae, it also offers reliability in cost and supply chain stability.”

Aside from this breakthrough product, dsm-firmenich announces developments across its entire life’s® portfolio. This includes the milestone introduction of life’s®OMEGA O3020 to the North American market in early 2024, which recently received regulatory approval in EMEA. 

life’s®OMEGA O3020 is the first and only single-source algal omega-3 with the same EPA-to-DHA ratio naturally found in standard fish oil, but with twice the potency and desirable organoleptic properties. dsm-firmenich has also been developing and will be launching two new highly potent, EPA-rich products in early 2025, further expanding the life’s®portfolio with a range of options that meet consumers’ diverse nutritional needs, health benefits, and format preferences.

For more information on life’sDHA® B54-0100 or the broader life’s® family, visitors to SupplySide West 2024 can drop by booth 4465 to speak to one of dsm-firmenich’s experts. 

More news from dsm-firmenich

Health, nutrition and care solutions from dsm-firmenich

dsm-firmenich: Nurturing people and planet with sustainable product innovations